Fairfield Current |
Omega Diagnostics First Half Revenue Down Following Reduced Operations
Morningstar In April, Omega completed a strategic review, resulting in decision to focus on its Visitect CD4 advanced disease teast, as well as its allergy and food intolerance businesses, reducing its cost base significantly. In line with this, Omega sold off its ... Omega Diagnostics highlights challenges as it reports losses |
from india intolerance - Google News https://ift.tt/2Qvpwj8
Comments
Post a Comment